Related Experiment Video
Updated: Jan 7, 2026
Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial
Published on: September 29, 2015
Growth factor and cell content in Platelet-Rich Plasma (PRP), Leukocyte- and Platelet-Rich Plasma (L-PRP),
Valeriia Husak1,2, Olena Povelychenko3, Valentyna Maltseva4
1Department of Transplantation of the Musculoskeletal System, Sytenko Institute of Spine and Joint Pathology, National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine. husakvaleria@gmail.com.
Background:
In contemporary regenerative medicine, platelet concentrates (PCs) are actively used as a promising method to support the regenerative process. However, the lack of standardized preparation protocols and the selection of PC types limits their broad clinical implementation, particularly in patients with non-unions or bone defects. Therefore, the aim of this study was to determine the concentration of platelets, leukocytes, and growth factors such as vascular endothelial growth factor (VEGF-A), transforming growth factor beta (TGF-β1), platelet-derived growth factor (PDGF-BB) in three types of PC, such as platelet-rich plasma (PRP), leukocyte- and platelet-rich plasma (L-PRP), platelet-rich fibrin (PRF) using a single donor model in patients with large bone defects after combat trauma compared to healthy individuals.
Methods:
Blood for PRP, L-PRP and PRF was collected from 30 participants. 19 healthy volunteers and 11 patients with long bone defects after combat injuries. For the production of three types of PC, 15 ml of blood was taken from each participant. The cellular composition was determined using an automated hematological analyzer. The concentration of growth factors VEGF-A, TGF-β1, PDGF-BB was determined by ELISA.
Results:
Differences in cellular composition and growth factor concentration between PC types were identified in all study participants. The concentration of platelets in PCs was distributed as follows: L-PRP > PRP > PRF; however, this did not affect the concentration of growth factors. The concentration of growth factors in PCs from patients with bone defects did not differ from that of healthy individuals. In patients with bone defects, it was not possible to achieve an enrichment of leukocyte concentration in L-PRP compared to the baseline level of whole blood; however, this parameter did not differ from that of healthy individuals.
Conclusions:
Growth factor concentrations were similar in patients and healthy individuals, but patients had differences in L-PRP leukocyte enrichment and lower platelet recovery in PRF. This study highlights the need to consider platelet concentrate characteristics when selecting products for regenerative therapy.
Clinical Trial Number:
Not applicable.
More Related Videos
07:51Effects of Allogeneic Platelet-Rich Plasma PRP on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description
Published on: March 19, 2018
06:36PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
Related Concept Videos
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
01:16Clot Retraction and Fibrinolysis